Ng CE - Search Results

1

Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2022 Sep;56(5):894-895. doi: 10.1111/apt.17160. Aliment Pharmacol Ther. 2022. PMID: 35934862 No abstract available.

2

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2022 May;55(10):1311-1319. doi: 10.1111/apt.16816. Epub 2022 Feb 15. Aliment Pharmacol Ther. 2022. PMID: 35166374 Free PMC article.

3

Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2022 May;55(9):1220-1221. doi: 10.1111/apt.16917. Aliment Pharmacol Ther. 2022. PMID: 35429032 No abstract available.

4

Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2022 Jul;56(1):110-120. doi: 10.1111/apt.16939. Epub 2022 May 1. Aliment Pharmacol Ther. 2022. PMID: 35491477 Free PMC article.

5

Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2022 Jun;55(12):1590-1591. doi: 10.1111/apt.16966. Aliment Pharmacol Ther. 2022. PMID: 35610938 No abstract available.

6

Impact of Rome IV irritable bowel syndrome on work and activities of daily living.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2022 Sep;56(5):844-856. doi: 10.1111/apt.17132. Epub 2022 Jul 6. Aliment Pharmacol Ther. 2022. PMID: 35794733 Free PMC article.

7

Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Neurogastroenterol Motil. 2023 Feb;35(2):e14483. doi: 10.1111/nmo.14483. Epub 2022 Sep 30. Neurogastroenterol Motil. 2023. PMID: 36178331 Free PMC article.

8

Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.

Goodoory VC, Guthrie EA, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2023 Feb;57(3):323-334. doi: 10.1111/apt.17356. Epub 2022 Dec 21. Aliment Pharmacol Ther. 2023. PMID: 36544055 Free article.

9

Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' reply.

Goodoory VC, Guthrie EA, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Among authors: ng ce. Aliment Pharmacol Ther. 2023 Mar;57(6):725-726. doi: 10.1111/apt.17404. Aliment Pharmacol Ther. 2023. PMID: 36821754 No abstract available.

10

Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden.

Black CJ, Ng CE, Goodoory VC, Ford AC. Black CJ, et al. Among authors: ng ce. Clin Gastroenterol Hepatol. 2024 Feb;22(2):386-396.e10. doi: 10.1016/j.cgh.2023.02.016. Epub 2023 Feb 27. Clin Gastroenterol Hepatol. 2024. PMID: 36858142 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters